Splenectomy Following JAK1/JAK2 Inhibitor Therapy in Patients With Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation

ConclusionSplenectomy before alloHSCT might be a promising option in patients who failed to achieve significant spleen response after ruxolitinib therapy.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research